YM BioSciences Receives Clearance to Initiate Randomized Double ... PharmaLive.com (press release), PA - Jan 6, 2009 CONTACT: Enquiries: Thomas Fechtner, the Trout Group LLC, Tel. (646)378-2931, Email: ; James Smith, the Equicom GroupInc., Tel. (416) 815-0700 x 229, ... YM BioSciences Nimotuzumab Selected for Multinational Phase III ... PharmaLive.com (press release) all 44 news articles |